Form 4: Healthcare Services Group Director Acquires Shares Through Deferred Stock Unit Plan

Sentiment:

Insider Transaction Report


Healthcare Services Group Inc. Director Kurt Simmons JR acquired 999 shares of common stock on June 30, 2025, through a pre-arranged deferred stock unit plan, bringing his total beneficial ownership to 25,704 shares.

Summary

  • Director Kurt Simmons JR of Healthcare Services Group Inc. (HCSG) acquired 999 shares of common stock.
  • The transaction occurred on June 30, 2025, at a price of $15.03 per share.
  • This acquisition was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged transaction.
  • The shares represent fully vested Deferred Stock Units (DSUs) received in lieu of cash fees for service on the Issuer's Board of Directors and committees.
  • The election to receive DSUs was made in November 2022, applying to director's fees earned in 2023.
  • The number of shares was determined by dividing the fee amount by the Issuer's closing stock price on the date such fees would otherwise be paid, rounded up to the nearest whole share.
  • Following this transaction, Kurt Simmons JR beneficially owns 25,704 shares, comprising 2,806 unvested DSUs and 22,898 vested DSUs.
  • These DSUs are set to settle in common stock on the first to occur of January 1, 2029, the participant's date of death, disability or separation from service, or a Change of Control.

Sentiment

Score: 7

Explanation: The transaction indicates a director's commitment to the company by opting for equity compensation, which is generally viewed positively as it aligns interests with shareholders. It's a routine compensation event rather than a significant strategic announcement, hence a moderate positive score.

Positives

  • The director's election to receive equity (DSUs) instead of cash fees aligns management's interests with shareholders, demonstrating commitment to the company's long-term performance.
  • The transaction was part of a pre-arranged Rule 10b5-1(c) plan, indicating a structured and compliant approach to equity compensation and insider trading.

Risks

  • The value of the Deferred Stock Units (DSUs) and the underlying common stock is subject to market fluctuations, which could impact the ultimate value realized by the director.
  • Settlement of the DSUs is contingent on future events (January 1, 2029, or specific personal/corporate events), introducing a time-based risk for liquidity and realization of value.

Future Outlook

The Deferred Stock Units (DSUs) are scheduled to settle in shares of common stock on the first to occur of January 1, 2029, the participant's date of death, disability or separation from service, or the date of a Change of Control. The reporting person may elect a further deferral beyond the initial settlement date pursuant to the rules of Code Section 409A.

Management Comments

  • The reporting person has elected to receive fully vested shares of Deferred Stock Units ("DSUs") under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees payable for service on the Issuer's Board of Directors and any committees thereof.

Industry Context

This transaction reflects a common practice in corporate governance where directors receive equity compensation to align their interests with shareholders. It is typical for companies in the healthcare services sector, like Healthcare Services Group, to use such incentive plans to retain and motivate key personnel and foster long-term commitment.

Comparison to Industry Standards

  • The use of Deferred Stock Units (DSUs) as a form of director compensation is a standard practice across various industries, including healthcare services, aligning director incentives with long-term shareholder value.
  • The election to receive equity in lieu of cash, as seen with Kurt Simmons JR, is a common feature in well-structured corporate incentive plans, similar to those at companies like Aramark (ARMK) or Sodexo (SW.PA), which also operate in facility services and food management.
  • The Rule 10b5-1(c) plan ensures the transaction is pre-scheduled and compliant with insider trading regulations, representing a best practice for corporate insiders to avoid accusations of trading on material non-public information.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Compensation PolicyDirector elected to receive fully vested Deferred Stock Units (DSUs) under the Issuer's 2020 Omnibus Incentive Plan in lieu of cash fees for Board service, aligning director compensation with equity performance.2022-11Enhances alignment of director's financial interests with long-term shareholder value and reinforces the company's commitment to equity-based incentives for its leadership.

Stakeholder Impact

  • Shareholders: The transaction positively aligns the director's financial interests with long-term shareholder value through equity compensation.
  • Management/Employees: Reinforces the company's use of equity-based incentive plans for key personnel, potentially boosting morale and retention.

Next Steps

  • Settlement of Deferred Stock Units (DSUs) into common stock on the first to occur of January 1, 2029, the participant's death, disability or separation from service, or a Change of Control.
  • Potential for the reporting person to elect a further deferral of DSU settlement beyond the initial settlement date pursuant to Code Section 409A rules.

Key Dates

DateDescription
2022-11Reporting person elected to receive Deferred Stock Units (DSUs) in lieu of cash fees for Board service.
2023Period for which director's fees were earned, to be paid in DSUs.
2025-06-30Transaction Date for the acquisition of 999 shares of common stock.
2025-07-02Signature Date of the Form 4 filing.
2029-01-01Earliest potential settlement date for Deferred Stock Units (DSUs).

Keywords

Healthcare Services Group, HCSG, Form 4, Insider Transaction, Director Compensation, Deferred Stock Units, Equity Compensation, Rule 10b5-1, Stock Acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.